Osteopenia Completed Phase 2 Trials for Cholecalciferol (DB00169)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004488Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's DiseaseTreatment